title: Serum estradiol and risk of stroke in elderly men.
abstract: OBJECTIVE
  To determine if levels of serum estradiol and testosterone can predict stroke in a population-based sample of elderly men.
  
  
  METHODS
  Serum 17beta estradiol and testosterone were measured in 2,197 men aged 71 to 93 years who participated in the Honolulu-Asia Aging Study from 1991 to 1993. All were free of prevalent stroke, coronary heart disease, and cancer. Participants were followed to the end of 1998 for thromboembolic and hemorrhagic events.
  
  
  RESULTS
  During the course of follow-up, 124 men developed a stroke (9.1/1,000 person-years). After age adjustment, men in the top quintile of serum estradiol (> or =125 pmol/L [34.1 pg/mL]) experienced a twofold excess risk of stroke vs men whose estradiol levels were lower (14.8 vs 7.3/1,000 person-years, p < 0.001). Among the lower quintiles, there were little differences in the risk of stroke. Findings were also significant and comparable for bioavailable estradiol and for thromboembolic and hemorrhagic events. After additional adjustment for hypertension, diabetes, adiposity, cholesterol concentrations, atrial fibrillation, and other characteristics, men in the top quintile of serum estradiol continued to have a higher risk of stroke vs those whose estradiol levels were lower (relative hazards = 2.2; 95% CI = 1.5 to 3.4, p < 0.001). Testosterone was not related to the risk of stroke.
  
  
  CONCLUSIONS
  High levels of serum estradiol may be associated with an elevated risk of stroke in elderly men.
authors.affiliation: Division of Biostatistics and Epidemiology, University of Virginia School of Medicine, Charlottesville, VA 22908-0717, USA. rda3e@virginia.edu
authors.forename: R D
authors.initials: RD
authors.lastname: Abbott
authors.forename: L J
authors.initials: LJ
authors.lastname: Launer
authors.forename: B L
authors.initials: BL
authors.lastname: Rodriguez
authors.forename: G W
authors.initials: GW
authors.lastname: Ross
authors.forename: P W F
authors.initials: PW
authors.lastname: Wilson
authors.forename: K H
authors.initials: KH
authors.lastname: Masaki
authors.forename: D
authors.initials: D
authors.lastname: Strozyk
authors.forename: J D
authors.initials: JD
authors.lastname: Curb
authors.forename: K
authors.initials: K
authors.lastname: Yano
authors.forename: J S
authors.initials: JS
authors.lastname: Popper
authors.forename: H
authors.initials: H
authors.lastname: Petrovitch
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood*; D044466:Asian People / Q000208:ethnology; D002543:Cerebral Hemorrhage / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology; D015331:Cohort Studies; D004958:Estradiol / Q000097:blood*; D006254:Hawaii / Q000453:epidemiology; D006801:Humans; D020767:Intracranial Thrombosis / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology; D008137:Longitudinal Studies; D008297:Male; D011237:Predictive Value of Tests; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000097:blood* / Q000453:epidemiology* / Q000503:physiopathology; D013739:Testosterone / Q000097:blood; D013923:Thromboembolism / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology
chemical_list: D013739:Testosterone; D004958:Estradiol